Clinical trial Recruiting at 4 sites Observational Ages 18 and up

Registry for patients with acute ischemic stroke caused by large vessel occlusions

Official title: Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2 (TRACK-LVO-2): an Imaging-based Patient Registry Study

Run by Tianjin Huanhu Hospital · NCT05659160 · Data updated 2026-11-12

This study is collecting information from patients with acute ischemic stroke caused by large vessel blockages to see if a special treatment works better than standard care.

More Large Vessel Occlusion trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorTianjin Huanhu Hospital
Academic / other
Locations4 sites (Tianjin, Tianjin Municipality and 3 other locations)
StatusRecruiting
StartedNovember 1, 2021
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedDecember 1, 2023
Trial IDNCT05659160 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have been diagnosed with acute ischemic stroke and confirmed large vessel occlusion.

Probably not a fit

Patients who do not have a confirmed diagnosis of acute ischemic stroke or large vessel occlusion may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to collect data from patients admitted with acute ischemic stroke (AIS) due to large vessel occlusions (LVO) across multiple centers. It will compare the effectiveness of endovascular therapy (EVT) and best medical management (BMM) in treating these patients. The study will gather demographic information, imaging characteristics, and treatment outcomes to identify optimal imaging modalities for LVO detection and assess the prognosis of patients receiving different treatments. The findings are expected to enhance the understanding and management of LVO in AIS patients.

Why it matters

Potential benefit: If successful, this study could lead to improved detection and treatment strategies for patients suffering from acute ischemic stroke due to large vessel occlusions.

How similar studies have gone: Other studies have shown success in using observational registries to improve treatment outcomes for stroke patients, making this approach promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient admitted from Jan. 1st 2018 to Jan. 1st 2028;
2. Age ≥ 18;
3. Ischemic stroke confirmed by head CT or MRI;
4. Large vessel occlusion confirmed by head CTA or MRA: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA), and posterior cerebral artery (PCA P1/P2);
5. Patients receiving either endovascular therapy or best medical treatment;

Exclusion Criteria:

\- None

Where it's running

  • Tianjin Medical University General Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting
  • The Sencond Hospital of Tianjin Medical University
    Tianjin, Tianjin Municipality, China
    Recruiting
  • Tianjin Huanhu Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting
  • Beijing University Binhai Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.